LXRs激动剂通过抑制STING依赖的I型干扰素反应来缓解脂肪移植诱导的认知功能障碍
Juan Li1, Yanqiong Wu2, Fan Jiang1
1Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
International immunopharmacology
|January 20, 2026
概括
脂肪组织功能障碍通过cGAS-STING通路导致神经病痛的认知衰退. 激活LXRβ可以通过抑制该途径来缓解这种情况,从而提供新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 代谢性疾病是一种代谢性疾病.
背景情况:
- 认知能力下降经常与神经病痛一起观察到.
- 脂肪组织代谢与认知功能障碍有关.
研究的目的:
- 为了研究脂肪组织和神经病痛引起的认知功能障碍之间的联系.
- 探索cGAS-STING通路和LXRβ在这个过程中的作用.
主要方法:
- 在小鼠中构建脂肪组织移植模型.
- 对双链DNA (dsDNA) 表达,cGAS-STING通路激活,I型干扰素反应和微质激活的分析.
- 使用肝X受体β (LXRβ) 激动剂.
主要成果:
- 脂肪组织移植加剧了认知功能障碍.
- 增加的dsDNA水平激活了cGAS-STING通路,导致干扰素反应和微质激活.
- 通过抑制cGAS-STING通路,LXRβ激动剂治疗改善了认知功能障碍.
结论:
- 脂肪组织功能障碍有助于神经病痛相关的认知衰退.
- cGAS-STING通路和微质激活是关键的调解者.
- LXRβ激动剂代表了对认知功能障碍的潜在治疗策略.
相关概念视频
Feedback Inhibition
56.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Types of Responses of Series RLC Circuits
1.7K
A second-order differential equation characterizes a source-free series RLC circuit, marking its distinct mathematical representation. The complete solution of this equation is a blend of two unique solutions, each linked to the circuit's roots expressed in terms of the damping factor and resonant frequency.
1.7K
Cognitive Dissonance
36.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
36.8K
Glucagon-like Receptor Agonists
867
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
867
Adrenergic Agonists: Therapeutic Uses
1.8K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.8K
Drug-Receptor Interaction: Agonist
4.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K


